Peptide Decoding
New?New to peptides?Start here →
Decoding

SS-31 (Elamipretide)_Dosage, benefits & legal status

Also known as elamipretide, Forzinity, MTP-131, Bendavia, SS-31, BioAmplify

Published July 22, 2026 · Updated August 24, 2026

A mitochondrial peptide, approved in 2025 for the rare genetic disease Barth syndrome.

Mitochondrial energyMitochondrial peptideFDA-approved
Common vial size50 mg
Dose40 mg per day
FrequencyDaily
RouteUnder the skin (subcutaneous)
StatusFDA-approved (accelerated)
CycledNot cycled

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

01

What is SS-31 (Elamipretide)?

Plain language first. The technical label stays, but it never stands alone.

Overview

It helps damaged mitochondria make energy again. It also cuts down harmful waste from that process. It is in real trials for mitochondrial and heart disease.

The technical version

SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide that binds and stabilizes cardiolipin, a fat in the inner wall of your cells' power plants.

What it's used for

A shot that targets your cells' energy factories to fight fatigue and support aging muscle, heart, and eyes. It is in real clinical trials for mitochondrial disease.

02

How does SS-31 (Elamipretide) work?

What it does in the body, and where.

SS-31 targets one specific molecule inside your mitochondria: cardiolipin, a fat that makes up part of the inner wall where energy is actually produced.

  1. 01
    It concentrates inside mitochondria
    The peptide is built to accumulate there rather than spread through the cell, which is unusual and is the reason it works at low doses.
  2. 02
    It binds and stabilises cardiolipin
    When cardiolipin is damaged, the energy-producing machinery attached to it stops working properly. Stabilising it restores the structure.
  3. 03
    Approved for one rare disease
    It was approved in 2025 as Forzinity for Barth syndrome, a rare genetic mitochondrial condition. Broader anti-aging use is not what it was approved for.
Pathway
THE PEPTIDESS-31 (Elamipreti…ACTS ONCardiolipin in mitochondriaRESULTDamaged cells make …RESULTFewer harmful bypro…

A schematic of the compound's mechanism, not a diagnostic image.

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Improving muscle strength in Barth syndrome, a rare inherited disease. This is its approved useFDA-approved
  • Other mitochondrial diseasesInvestigational
  • Age-related muscle decline and eye conditionsInvestigational
  • Energy and fatigue generally, which is why most people seek it outEarly research

The published record

Research index

506

Records indexed for SS-31 (Elamipretide)400 papers and 30 trials indexed in detail.

175 in humans, 76 of them original studies.

30 registered trials, 14 with posted results.

FDA: Named as an unapproved new drug.

Browse the records

In animalsPro
In the labPro
ReviewsPro
Senior author sharePro

Counted from Europe PMC indexing, not read by a person. Human means indexed under humans, which includes reviews and work on human cells. Original studies exclude reviews and lab work on human cells.Last updated 12 September 2026.

SS-31 (Elamipretide) vial rendering
Compound field notes

At a glance

Four things to know about SS-31 (Elamipretide)

01

Evidence

FDA-approved

02

Category

Longevity and energy

03

Common vial

50 mg

04

Half-life

Not stated on the label

04

How much, and do you cycle it?

The range, and whether you take breaks.

40 mg per day, daily. Not cycledFDA label

Taken continuously for as long as it is working. Neither the label nor clinical practice describes an on/off schedule.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Not stated on the labelNo figure

The Forzinity label has no half-life in it. Section 12.3 gives time to peak concentration of 0.5 to 1 hour, 92 percent bioavailability, and near-complete recovery in urine by 48 hours, which points to a short half-life without stating one. The 2 to 3 hour figure circulating online does not come from the label.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced dose: 40 mg per dayFDA label

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

Your draw

160 / 100 units
160 units will not fit in a 100-unit syringe. It would take 2 separate draws, or you can mix with less water so it fits in one.
What it costs

SS-31 (Elamipretide) starts at $31.99 across 32 vendors, typically $2.30 – $10.00 per mg.

51 listings, last read Sep 6, 2026. Shipping and card fees are not included.

See all 51 listings →
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized SS-31 (Elamipretide) keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • No formal contraindications were established at approval
  • Pregnancy, where it has not been studied

Stop and get help

These are emergencies. Seek care.
  • Signs of a serious allergic reaction such as trouble breathing, swelling, or a severe rash, which has required permanent discontinuation in rare cases

Common effects

Expected, and usually mild.
  • Injection-site reactions, which are the most common effect
  • Otherwise generally well tolerated in trials

What regulators say

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is SS-31 (Elamipretide) approved?

And where the numbers on this page come from.

Yes. SS-31 (Elamipretide) is FDA approved and available on prescription in the United States.

  • Approval status
    FDA-approved
  • Route
    Under the skin (subcutaneous)
  • Checked
    July 2026

What has happened recently

Granted FDA accelerated approval on 19 September 2025 as Forzinity, for Barth syndrome in patients weighing at least 30 kg. This followed a rejection in May 2025. Accelerated approval means confirmatory data is still required.

You can compare this against the whole library, or read how to check a seller.


  • DoseFrom the drug label. The manufacturer tested this range and a regulator reviewed it.
  • Vial sizeFrom what vendors typically list; not a recommendation.
  • Sources
  • Reviewed22 July 2026
10

What else is like SS-31 (Elamipretide)?

Others in Longevity and energy, side by side.

If you're weighing SS-31 (Elamipretide), it's worth reading FOXO4-DRI, Vesugen, and Bronchogen in the same class.

Guides for this compound

Sources

Last reviewed 22 July 2026

Beyond these, 430 records are indexed. Browse the records